Rhabdomyolysis as a rare severe complication of statin therapy: differential diagnosis in real clinical practice (a clinical case)
The mechanisms of drug-induced myopathies include direct myotoxicity, immune-mediated and indirect muscle damage. Clinical manifestations range from asymptomatic or minor myalgia and muscle weakness to chronic myopathy with severe weakness and, in rare cases, rhabdomyolysis with release of cellular...
Saved in:
| Main Authors: | A. V. Melekhov, S. V. Borisovskaya, N. S. Gavrilina, I. I. Gaponova, I. G. Nikitin, O. A. Ettinger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2025-06-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/3110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins: Adherence and side-effects
by: D.J. Blom
Published: (2011-07-01) -
Statin therapy for NAFLD: Molecular underpinnings of myopathic consequences and treatment strategies
by: Pratiksha Nanepag, et al.
Published: (2025-06-01) -
MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT
by: O. M. Drapkina, et al.
Published: (2015-09-01) -
MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
by: A. S. Kazakov, et al.
Published: (2018-09-01) -
New experimental possibilities for statin myopathy diagnosing
by: E. V. Vinogradova, et al.
Published: (2021-07-01)